John F. Maroney
In July 2013, John accepted the CEO position at ForSight VISION 5, a new Delphi Ventures VIII portfolio company. John has been part of the Delphi Ventures investment team for over ten years. During his tenure with Delphi, he has focused on early stage medical device investments. Along with his new position at ForSight VISION 5, John will continue his board of directors relationships with three Delphi Ventures portfolio companies.
Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. (NYSE:BSX) in 2007. From 1988 to 1997, John held a variety of senior management positions including President and General Manager at EP Technologies, Vice President of Operations at both Boston Scientific Corporation and Cardiovascular Imaging Systems (CVIS). While at CVIS, John was a key member of the senior management team during the Company's IPO and eventual acquisition by Boston Scientific Corporation. John also serves on the Advisory Board for the School of BioMedical Engineering at UC Davis.
- B.S. Mechanical Engineering, University of California, Davis
REPRESENTATIVE INVESTMENTS AND BOARD INVOLVEMENT
- EBR Systems, Inc.
- EndoTex Interventional Systems, Inc. a.b. Boston Scientfic Corp. (BSX)
- Lutonix, Inc. a.b. C.R. Bard, Inc. (BCR)
- Pivot Medical, Inc.
- VytronUS, Inc.